US Stock MarketDetailed Quotes

GLTO Galecto

Watchlist
  • 0.608
  • -0.002-0.33%
Close May 31 16:00 ET
16.48MMarket Cap-538P/E (TTM)

About Galecto Company

Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3, lysyl oxidase-like 2, and LOXL2. The company was founded by Ulf J?rgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsg?rd Schambye in 2011 and is headquartered in Boston, MA.

Company Profile

SymbolGLTO
Company NameGalecto
Listing DateOct 29, 2020
Issue Price15.00
Founded2011
CEODr. Hans T. Schambye, M.D.,PhD
MarketNASDAQ
Employees13
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address75 State Street,Suite 100
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02109
Phone1-45-070-5210
Websitehttp://www.galecto.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Hans T. Schambye, M.D.,PhD
  • Director, President and Chief Executive Officer
  • 965.12K
  • Jonathan Freve
  • Chief Financial Officer and Principal Accounting Officer
  • 701.33K
  • Dr. Carl S. Goldfischer,M.D.
  • Chairman of the Board
  • 155.19K
  • Dr. David Shapiro, M.D.
  • Independent Director
  • 148.84K
  • Dr. Anne Prener, M.D.,PhD
  • Independent Director
  • 83.85K
  • Chau Q. Khuong
  • Independent Director
  • 83.85K
  • Amit D. Munshi
  • Independent Director
  • 78.85K
  • Dr. Soren Moller, PhD
  • Independent Director
  • --
  • Dr. Jayson Dallas, M.D.
  • Independent Director
  • 86.35K
  • Garrett Winslow
  • General Counsel and Corporate Secretary
  • 554.39K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg